Background Inappropriate polypharmacy is a particular concern in older people and is
associated with negative health outcomes. Choosing the best interventions to improve …

Background Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death
and disability worldwide, yet ASCVD risk factor control and secondary prevention rates …

Background Cardiovascular disease (CVD) is the leading cause of death and disability
worldwide, yet CVD risk factor control and secondary prevention rates remain low. A fixed …

Abstract Purpose of Review To summarize the recent evidence on the effectiveness and
safety of antihypertensive fixed-dose combination (FDC) medications, and to describe the …

Statistical experimental design and Derringer's desirability function were applied to develop
an improved RP‐HPLC method for the simultaneous analysis of amlodipine and atorvastatin …

Hypertension and dyslipidemia are two of the most commonly co-occurring cardiovascular
risk factors which together cause an increase in coronary heart disease-related events that …

Abstract The Gemini-AALA (Australia, Asia, Latin America, Africa/Middle East) study
evaluated the efficacy and safety of single-pill amlodipine/atorvastatin (Caduet) for the …

Cardiovascular disease (CVD) is the leading cause of death among men and women
worldwide. In CVD, hypertension and dyslipidemia commonly coexist and are managed …

Purpose A fixed-dose combination of a stain and an antihypertensive drug may be useful for
the treatment of patients with hypertension and hyperlipidemia. It may also improve patient …

Amlodipine/atorvastatin (Caduet®) is a once-daily fixed-dose combination of the
dihydropyridine calcium channel antagonist amlodipine and the HMG-CoA reductase …